Analysis of relapse rates and risk factors of tapering or stopping pharmacologic therapies in axial spondyloarthritis patients with sustained remission

Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

Pedro Machado, Robert Landewé, E. Lie et al. · Annals of the Rheumatic Diseases · 2010 · 797 citations

Medicine, Clinical Sciences, Pharmacotherapy +10

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

Denis Poddubnyy, Martín Rudwaleit, Hildrun Haibel et al. · Annals of the Rheumatic Diseases · 2012 · 331 citations · Full text

Medicine, Oncology, Immuno-oncology Pharmacotherapy +12

Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)

Joachim Sieper, Joachim Listing, Denis Poddubnyy et al. · Annals of the Rheumatic Diseases · 2015 · 227 citations · Full text

Medicine, Pharmacotherapy, Orthopedics +13

Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis—a population-based survey

Jane Zochling, M. Bohl-Bühler, Xenofon Baraliakos et al. · Clinical Rheumatology · 2006 · 69 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +7

A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study

Jakub Závada, Michal Uher, K. Sisol et al. · Annals of the Rheumatic Diseases · 2014 · 67 citations

Medicine, Clinical Sciences, Pharmacotherapy +14